GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE

글리칸-상호작용 항체를 투여하는 단계를 포함하는 암 치료 방법이 제공된다. 바람직한 생체 활성, 생물학적 이용 가능성, 및 독성 수준을 달성하는데 적합한 항-시알릴 Tn 항원 항체와 관련 조성물 및 제제가 포함된다. Methods of treating cancer are provided that include administering glycan-interacting antibodies. Included are anti-sialyl Tn antigen antibodies and related compositions and formu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	EAVARONE DAVID A, PRENDERGAST JILLIAN M, DRANSFIELD DANIEL T
Format:	Patent
Sprache:	eng ; kor
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	글리칸-상호작용 항체를 투여하는 단계를 포함하는 암 치료 방법이 제공된다. 바람직한 생체 활성, 생물학적 이용 가능성, 및 독성 수준을 달성하는데 적합한 항-시알릴 Tn 항원 항체와 관련 조성물 및 제제가 포함된다. Methods of treating cancer are provided that include administering glycan-interacting antibodies. Included are anti-sialyl Tn antigen antibodies and related compositions and formulations suitable to achieve desirable bioactivity, bioavailability, and toxicity levels.